Back to top
more

Align Technology (ALGN)

(Delayed Data from NSDQ)

$212.15 USD

212.15
651,165

+1.37 (0.65%)

Updated Nov 5, 2024 04:00 PM ET

After-Market: $211.69 -0.46 (-0.22%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Dental Supplies

Zacks News

Intuitive Surgical (ISRG) Stock Gains 20% YTD: Here's Why

Intuitive Surgical (ISRG) shares gain on the back of growth in the da Vinci treatment volume and raised procedure prices.

Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now

Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. Gross margins improve. However, the rising cost of products is a concern.

ResMed (RMD) Up 16.3% Since Last Earnings: Will it Continue?

Investors are optimistic about ResMed (RMD) led by strong growth in the U.S. mask and accessories business and its cloud-connected platforms.

Inari Medical (NARI) Sues Truvic on Patent Infringement

Inari Medical (NARI) files a patent infringement lawsuit against Imperative Care and its subsidiary Truvic over intentionally copying and overlapping the designs of Inari Medical's products.

Integer Holdings (ITGR) Gains 23.6% YTD: What's Driving the Stock?

Integer Holdings (ITGR) shares soar on the back of growth in the Medical segment. However, fluctuations in raw material prices and the oil and energy market are concerning.

Stereotaxis' (STXS) RMN System to Aid in Treating Arrhythmias

Stereotaxis (STXS) announces the completion of treatment of first heart rhythm patients with its Genesis Robotic Magnetic Navigation system in Southern Italy.

Why Is Align Technology (ALGN) Down 18.7% Since Last Earnings Report?

Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Add Ecolab (ECL) to Your Portfolio Now

Ecolab's (ECL) focus on research and development raises optimism about the stock.

Intuitive Surgical (ISRG) Hits 52-Week High on Procedure Demand

Intuitive Surgical's (ISRG) da Vinci procedure volume, coupled with strong Ion procedure growth, is fueling the rally in the company???s share price.

AngioDynamics' (ANGO) AlphaVac System Gets CE Mark Approval

AngioDynamics (ANGO) announces the European CE Mark approval of its AlphaVac F1885 System, which is likely to expand the range of therapy alternatives available to pulmonary embolism patients.

DaVita (DVA) Gains 34.5% YTD: What's Driving the Stock?

DaVita's (DVA) shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.

McKesson (MCK) Hits 52-Week High: What's Driving the Stock?

Investors are optimistic about McKesson's (MCK) strength in its Biologics business.

Philips' (PHG) Reports Positive AI-Powered Cardiac Study Data

Philips' (PHG) AI-powered cardiac monitoring solutions demonstrate significantly lower re-admissions and a higher rate of survival in the retrospective study evaluating it in stroke patients.

Here's Why You Should Hold Surmodics (SRDX) Stock for Now

Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.

Down -9.19% in 4 Weeks, Here's Why You Should You Buy the Dip in Align Technology (ALGN)

Align Technology (ALGN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Veeva's (VEEV) Vault Basics to Boost Efficiency for Biotechs

Veeva (VEEV) announces the availability of Vault Basics for biotechs, which aims to deliver complete and pre-validated solutions for expanding businesses.

AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft

AxoGen (AXGN) starts the process of BLA submission to the FDA for the approval of its Avance Nerve Graft.

Reasons to Retain DexCom (DXCM) Stock in Your Portfolio Now

DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.

Butterfly Network (BFLY) Unveils iQ+ Bladder Ultrasound Scanner

Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.

HealthEquity (HQY) Closes Conduent's BenefitWallet Acquisition

HealthEquity (HQY) completes the acquisition of Conduent's BenefitWallet HSA portfolio. This is likely to further strengthen the HSA business of HealthEquity.

Align Technology (ALGN) Gains From Innovation, Global Expansion

In the United States, Align Technology (ALGN) is focused on reaching young adults as well as teens and their parents through famous athletes, influencers and fashion designers.

Profound Medical (PROF) Adds AI to Prostate Cancer Treatment

Profound Medical's (PROF) Contouring Assistant integrates AI into prostate cancer procedures, thereby streamlining the treatment planning process and enhancing both efficiency and precision.

Reasons to Add Veeva Systems (VEEV) Stock to Your Portfolio

Veeva System's (VEEV) strong product demand and strategic deals raise optimism about the stock.

GE HealthCare (GEHC), Medis Medical Partner to Aid CAD Therapy

GE HealthCare (GEHC) and Medis Medical collaborate to boost precision care for coronary artery disease treatment.

Here's Why You Should Buy Align Technology (ALGN) Stock Now

Investors are optimistic about Align Technology (ALGN) led by expansion in new geographies and upbeat guidance.